Back to results
US 5,632,983 AGranted
Method for treating secondary immunodeficiency
AssigneeUniversity of South Florida
InventorJohn W. Hadden
Life of this patent
Estimating the term…
Abstract
A method of treating cellular immune deficiency in a patient including the steps of determining the presence of a cellular immune deficiency and co-administering to the patient an effective amount of a thymic peptide combined with an effective amount of an immunomodulating natural nonrecombinant cytokine preparation.
Claims2
A method of improving cellular immune response in a patient comprising
- coadministering to the patient an effective amount of a peptide selected from the group consisting of Thymosin .alpha..sub.1, Thymosin .alpha..sub.1 analogs and Thymosin .alpha..sub.1 fragments and an effective amount of a cellularly-produced nonrecombinant cytokine preparation wherein the nonrecombinant cytokine preparation contains a cytokine profile of IL-1 at 10-2000 pg/ml, IL-2 at 100-500 units/ml, IL-6 at 250-10,000 pg/ml, IL-8 at 12,000-100,000 pg/ml, IL-12 at 100-10,000 pg/ml, IFN-.gamma. at 50-15,000 pg/ml, TNF-.gamma. at 50-15,000 pg/ml, CSF-GM at 10-1560 pg/ml, and IL-3, IL-4, IL-7 present in trace amounts.
Dependencies are inferred from the claim text.